U.S.-based pharma giant makes $1.5 billion deal for rights to portfolio of drugs
Associated Press, San Jose Mercury News: Business
Thu, 08/25/2016 - 5:13am
U.S.-based pharma giant makes $1.5 billion deal for rights to portfolio of drugs